The Claim
Initiating allopurinol at 100 mg daily, increased to 200 mg daily after 14 days, during an acute gout attack in patients with crystal-proven gout, at least one indication for urate-lowering therapy, and normal kidney and liver function does not significantly prolong the duration of the acute attack compared to placebo.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Starting allopurinol at 100 mg per day and increasing to 200 mg per day after 14 days during an acute gout attack does not extend the length of the attack in patients with confirmed gout, a need for urate-lowering therapy, and normal kidney and liver function, when compared to a placebo.
See the scientific wording
Initiating allopurinol at 100 mg daily, increased to 200 mg daily after 14 days, during an acute gout attack in patients with crystal-proven gout, at least one indication for urate-lowering therapy, and normal kidney and liver function does not significantly prolong the duration of the acute attack compared to placebo.
When allopurinol lowers uric acid levels, existing urate crystals in the joint slowly dissolve without triggering more inflammation, so the flare doesn't get worse or last longer.
What the research says
1 studyStudy: Does Starting Allopurinol Prolong Acute Treated Gout? A Randomized Clinical Trial
This study found that starting a common gout medication (allopurinol) during a flare didn’t make the pain last longer than if patients got a dummy pill. So, it’s safe to begin the drug even while the flare is happening.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.